• Health & Medicine

Transforming optimism: finding new ways to treat rare cancers

We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma. We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.

27 January 2021

• Science & Technology
• Health & Medicine

Genetic changes in tumours may predict who will respond to immunotherapy

Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments.  Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments. 

27 January 2021

• Health & Medicine

Three new cancer drugs approved for NHS in Scotland

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma. The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

21 January 2021

• Health & Medicine

NHS patients among first to access new CAR T cell therapy for lymphoma

Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy. Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy.

20 January 2021

• Health & Medicine

NICE approves new maintenance treatment for ovarian cancer

A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer. A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.

19 January 2021

• Science & Technology
• Health & Medicine

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

14 January 2021

• Health & Medicine

COVID-19 in people with cancer – what we know so far

More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer. More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer.

7 January 2021

• Science & Technology
• Policy & Insight

We have a Deal: What does the new UK-EU relationship mean for cancer?

Here’s what we know about how the new UK-EU relationship may affect cancer services and research. Here’s what we know about how the new UK-EU relationship may affect cancer services and research.

4 January 2021

• Health & Medicine

New treatment could spare early-stage rectal cancer patients life-altering side effects

A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer. A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer.

10 December 2020

• Health & Medicine

Scottish Medicines Consortium says yes to chemotherapy-free leukaemia treatment

The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia. The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.

8 December 2020

• Health & Medicine

Prostate cancer treatment approved in England

Following its approval in Scotland 2 weeks ago, a new treatment will now be available on the NHS in England for some people with prostate cancer. Following its approval in Scotland 2 weeks ago, a new treatment will now be available on the NHS in England for some people with prostate cancer.

30 November 2020

• Health & Medicine

First ‘targeted’ bowel cancer treatment combo approved for NHS use in England 

The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.   The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.  

20 November 2020